Abstract:In Alzheimer's Disease (AD), amyloidogenic proteins (APs), such as β-amyloid (Aβ) and tau, may act as alarmins/damage-associated molecular patterns (DAMPs) to stimulate neuroinflammation and cell death. Indeed, recent evidence suggests that brain-specific type 2 immune networks may be important in modulating amyloidogenicity and brain homeostasis. Central to this, components of innate neuroimmune signaling, particularly type 2 components, assume distinctly specialized roles in regulating immune homeostasis and brain function. Whereas balanced immune surveillance stems from normal type 2 brain immune function, appropriate microglial clearance of aggregated misfolded proteins and neurotrophic and synaptotrophic signaling, aberrant pro-inflammatory activity triggered by alarmins might disrupt this normal immune homeostasis with reduced microglial amyloid clearance, synaptic loss, and ultimately neurodegeneration. Furthermore, since increased inflammation may in turn cause neurodegeneration, it is predicted that AP aggregation and neuroinflammation could synergistically promote even more damage. The reasons for maintaining such adverse biological conditions which have not been weeded out during evolution remain unclear. Here, we discuss these issues from a viewpoint of amyloidogenic evolvability, namely, aEVO, a hypothetic view of an adaptation to environmental stress by AP aggregates. Speculatively, the interaction of AP aggregation and neuroinflammation for aEVO in reproduction, which is evolutionally beneficial, might become a co-activating relationship which promotes AD pathogenesis through antagonistic pleiotropy. If validated, simultaneously suppressing both AP aggregation and specific innate neuroinflammation could greatly increase therapeutic efficacy in AD. Overall, combining a better understanding of innate neuroimmunity in aging and disease with the aEVO hypothesis may help uncover novel mechanism of pathogenesis of AD, leading to improved diagnostics and treatments.

Genomics of Alzheimer’s disease implicates the innate and adaptive immune systems

The role of the immune system in Alzheimer’s disease

The role of the immune system in Alzheimer's disease

Genome-Wide Association and Mechanistic Studies Indicate That Immune Response Contributes to Alzheimer’s Disease Development

Genome-Wide Association and Mechanistic Studies Indicate That Immune Response Contributes to Alzheimer's Disease Development

Immune attack: the role of inflammation in Alzheimer disease

Genomics and Functional Genomics of Alzheimer’s Disease

The adaptive immune system restrains Alzheimer’s disease pathogenesis by modulating microglial function

Inflammation in Alzheimer’s Disease and Molecular Genetics: Recent Update

The neuroimmune axis of Alzheimer's disease

Alzheimer’s Disease Variants with the Genome-Wide Significance are Significantly Enriched in Immune Pathways and Active in Immune Cells

The role of innate immunity in Alzheimer's disease

The association of microbial infection and adaptive immune cell activation in Alzheimer's disease

Genetic Studies of Alzheimer's Disease Risk Implicate Clearance of Lipid Rich Debris in Myeloid Cells

Integration of Alzheimer's Disease Genetics and Myeloid Cell Genomics Identifies Novel Causal Variants, Regulatory Elements, Genes and Pathways

Integration of Alzheimer’s Disease Genetics and Myeloid Genomics Reveals Novel Disease Risk Mechanisms

Myeloid Cells in Alzheimer's Disease: Culprits, Victims or Innocent Bystanders?

TLR4 Cross-Talk With NLRP3 Inflammasome and Complement Signaling Pathways in Alzheimer's Disease

Identification of Immune Cells and Key Genes associated with Alzheimer's Disease

Emerging Roles of Adaptive Immune Response in Alzheimer's Disease

Innate neuroimmunity across aging and neurodegeneration: a perspective from amyloidogenic evolvability